相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Secondary diabetes associated with 5-fluorouracil-based chemotherapy regimens in non-diabetic patients with colorectal cancer: results from a single-centre cohort study
J. -P. Feng et al.
COLORECTAL DISEASE (2013)
Marked Expansion of Exocrine and Endocrine Pancreas With Incretin Therapy in Humans With Increased Exocrine Pancreas Dysplasia and the Potential for Glucagon-Producing Neuroendocrine Tumors
Alexandra E. Butler et al.
DIABETES (2013)
Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies
D. Bansal et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2013)
Research on the relationships between pancreatic cancer and hyperglycemia in Chinese populations
Shan Huang et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
Glucagonlike Peptide 1-Based Drugs and Pancreatitis Clarity at Last, but What About Pancreatic Cancer?
Belinda Gier et al.
JAMA INTERNAL MEDICINE (2013)
The Impact of Obesity on Perioperative Outcomes After Laparoscopic Colorectal Resection
Tomoki Makino et al.
ANNALS OF SURGERY (2012)
Obesity and cancer risk: evidence, mechanisms, and recommendations
Ivana Vucenik et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2012)
Association between tamoxifen treatment and diabetes A Polulation-Based Study
Lorraine L. Lipscombe et al.
CANCER (2012)
A meta-analysis of serious adverse events reported with exenatide and liraglutide: Acute pancreatitis and cancer
Carlos Alves et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2012)
Relative risk of acute pancreatitis in initiators of exenatide twice daily compared with other anti-diabetic medication: a follow-up study
M. Wenten et al.
DIABETIC MEDICINE (2012)
Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials
R. J. Stevens et al.
DIABETOLOGIA (2012)
Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence
J. A. Johnson et al.
DIABETOLOGIA (2012)
Diabetes and Cancer: Epidemiological, Clinical, and Experimental Perspectives
Chin-Hsiao Tseng et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Prostate Carcinogenesis with Diabetes and Androgen-Deprivation- Therapy-Related Diabetes: An Update
Noboru Hara
EXPERIMENTAL DIABETES RESEARCH (2012)
Impact of Diabetes and Hyperglycemia on Survival in Advanced Breast Cancer Patients
Cynthia Villarreal-Garza et al.
EXPERIMENTAL DIABETES RESEARCH (2012)
Appropriate Chemotherapy Dosing for Obese Adult Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline
Jennifer J. Griggs et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Metformin and cancer: new applications for an old drug
Taxiarchis V. Kourelis et al.
MEDICAL ONCOLOGY (2012)
Basal Insulin and Cardiovascular and Other Outcomes in Dysglycemia
Hertzel C. Gerstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Why are diabetics at reduced risk for prostate cancer? A review of the epidemiologic evidence
Brandon L. Pierce
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
The Association between Obesity and Colorectal Cancer
Kevin Whitlock et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2012)
Hyperglycemia During Chemotherapy for Hematologic and Solid Tumors Is Correlated With Increased Toxicity
Antonella Brunello et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2011)
Associations of diabetes mellitus with site-specific cancer mortality in the Asia-Pacific region
E. K. K. Lam et al.
ANNALS OF ONCOLOGY (2011)
Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer
K. Nimptsch et al.
CANCER CAUSES & CONTROL (2011)
Metformin and Incident Breast Cancer among Diabetic Women: A Population-Based Case-Control Study in Denmark
Jaclyn Lee Fong Bosco et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2011)
Risk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone Interim report of a longitudinal cohort study
James D. Lewis et al.
DIABETES CARE (2011)
A cohort study of acute pancreatitis in relation to exenatide use
D. D. Dore et al.
DIABETES OBESITY & METABOLISM (2011)
Diabetes mellitus, other medical conditions and pancreatic cancer: a case-control study
Loren Lipworth et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)
Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort
V. A. Grote et al.
DIABETOLOGIA (2011)
The relationship between new-onset diabetes mellitus and pancreatic cancer risk: A case-control study
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies
Qiwen Ben et al.
EUROPEAN JOURNAL OF CANCER (2011)
Pancreatitis, Pancreatic, and Thyroid Cancer With Glucagon-Like Peptide-1-Based Therapies
Michael Elashoff et al.
GASTROENTEROLOGY (2011)
THE POTENTIAL PROTECTIVE EFFECT OF METFORMIN AGAINST PANCREATIC CANCER: PRELIMINARY RESULTS FROM A CASE-CONTROL STUDY IN TWO UK CENTRES
M. W. Little et al.
GUT (2011)
Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and Treatment study)
Emma L. Turner et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Hyperglycemia Regulates MDR-1, Drug Accumulation and ROS Levels Causing Increased Toxicity of Carboplatin and 5-Fluorouracil in MCF-7 Cells
Vimal Pandey et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2011)
Clinically Defined Type 2 Diabetes Mellitus and Prognosis in Early-Stage Breast Cancer
Kirsten Erickson et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Associations of Insulin Resistance and Adiponectin With Mortality in Women With Breast Cancer
Catherine Duggan et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Expression of microRNAs: potential molecular link between obesity, diabetes and cancer
A. S. Ali et al.
OBESITY REVIEWS (2011)
Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents
Krystyna Tatarkiewicz et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study
Qiang Li et al.
CANCER CAUSES & CONTROL (2010)
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Ian F. Godsland
CLINICAL SCIENCE (2010)
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES (2010)
Postoperative Mortality in Cancer Patients With Preexisting Diabetes Systematic review and meta-analysis
Bethany B. Barone et al.
DIABETES CARE (2010)
Acute Pancreatitis in Type 2 Diabetes Treated With Exenatide or Sitagliptin
Rajesh Garg et al.
DIABETES CARE (2010)
Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
Edoardo Mannucci et al.
DIABETES CARE (2010)
Diabetes and Cancer A consensus report
Edward Giovannucci et al.
DIABETES CARE (2010)
Inhibition of multifunctional dipeptidyl peptidase-IV: Is there a risk of oncological and immunological adverse effects?
Tomas Stulc et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2010)
Diabetes, prediabetes and cancer mortality
X. H. Zhou et al.
DIABETOLOGIA (2010)
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure
S. L. Bowker et al.
DIABETOLOGIA (2010)
Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes
J. A. Johnson et al.
DIABETOLOGIA (2010)
THE PATHWAY FROM DIABETES AND OBESITY TO CANCER, ON THE ROUTE TO TARGETED THERAPY
Emily J. Gallagher et al.
ENDOCRINE PRACTICE (2010)
Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase
L. Zeng et al.
ENDOCRINE-RELATED CANCER (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease
Graeme P. Williams
EUROPEAN JOURNAL OF CANCER PREVENTION (2010)
Prospective Study Reveals Associations Between Colorectal Cancer and Type 2 Diabetes Mellitus or Insulin Use in Men
Peter T. Campbell et al.
GASTROENTEROLOGY (2010)
Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis
S. S. Engel et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2010)
Obesity Increases Wound Complications in Rectal Cancer Surgery
Courtney J. Balentine et al.
JOURNAL OF SURGICAL RESEARCH (2010)
The International Study of Insulin and Cancer
L. Grimaldi-Bensouda et al.
LANCET (2010)
Cellular Metabolic Stress: Considering How Cells Respond to Nutrient Excess
Kathryn E. Wellen et al.
MOLECULAR CELL (2010)
Weighing Risks and Benefits of Liraglutide -- The FDA's Review of a New Antidiabetic Therapy.
Mary Parks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
The impact of obesity on outcomes of laparoscopic surgery for colorectal cancer in Asians
Ji Won Park et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2010)
Anthropometry and Esophageal Cancer Risk in the European Prospective Investigation into Cancer and Nutrition
Annika Steffen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Obesity and Cancer: The Role of Dysfunctional Adipose Tissue
Rob C. M. van Kruijsdijk et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
Majed S. Alokail et al.
CARDIOVASCULAR DIABETOLOGY (2009)
Do Cancer Cells Care If Their Host Is Hungry?
Michael Pollak
CELL METABOLISM (2009)
Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
David D. Dore et al.
CURRENT MEDICAL RESEARCH AND OPINION (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cells
Doron Weinstein et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2009)
Combined randomised controlled trial experience of malignancies in studies using insulin glargine
P. D. Home et al.
DIABETOLOGIA (2009)
Similar risk of malignancy with insulin glargine and neutral protamine Hagedorn (NPH) insulin in patients with type 2 diabetes: findings from a 5 year randomised, open-label study
J. Rosenstock et al.
DIABETOLOGIA (2009)
Does diabetes therapy influence the risk of cancer?
U. Smith et al.
DIABETOLOGIA (2009)
Insulin glargine use and short-term incidence of malignancies-a population-based follow-up study in Sweden
J. M. Jonasson et al.
DIABETOLOGIA (2009)
No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis
A. Dejgaard et al.
DIABETOLOGIA (2009)
Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group
H. M. Colhoun
DIABETOLOGIA (2009)
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
C. J. Currie et al.
DIABETOLOGIA (2009)
Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study
L. G. Hemkens et al.
DIABETOLOGIA (2009)
GLUCOCORTICOID-INDUCED HYPERGLYCEMIA
John N. Clore et al.
ENDOCRINE PRACTICE (2009)
Obesity and Cancer Part 1 of the Diabetes and Cancer Mini-Review Series
R. Percik et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)
Antidiabetic Therapies Affect Risk of Pancreatic Cancer
Donghui Li et al.
GASTROENTEROLOGY (2009)
POTENTIAL FOR HIGHER TREATMENT FAILURE IN OBESE PATIENTS: CORRELATION OF ELEVATED BODY MASS INDEX AND INCREASED DAILY PROSTATE DEVIATIONS FROM THE RADIATION BEAM ISOCENTERS IN AN ANALYSIS OF 1,465 COMPUTED TOMOGRAPHIC IMAGES
James R. Wong et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer
Sao Jiralerspong et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Obesity and Mammography: A Systematic Review and Meta-Analysis
Nisa M. Maruthur et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2009)
Insulin glargine and malignancy: an unwarranted alarm
Stuart J. Pocock et al.
LANCET (2009)
New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer
Rahul Pannala et al.
LANCET ONCOLOGY (2009)
The Association of Obesity and Cervical Cancer Screening: A Systematic Review and Meta-analysis
Nisa M. Maruthur et al.
OBESITY (2009)
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan et al.
DIABETES CARE (2009)
Type 2 diabetes mellitus and risk of non-Hodgkin lymphoma: A systematic review and meta-analysis
Chun Chao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Hormonal profile of diabetic men and the potential link to prostate cancer
Jocelyn S. Kasper et al.
CANCER CAUSES & CONTROL (2008)
Body Size and Risk of Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition
Tobias Pischon et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
Rosiglitazone and risk of cancer - A meta-analysis of randomized clinical trials
Matteo Monami et al.
DIABETES CARE (2008)
Diabetes and Risk of Non-Hodgkin's Lymphoma A meta-analysis of observational studies
Joanna Mitri et al.
DIABETES CARE (2008)
Rosiglitazone no longer recommended
[Anonymous]
LANCET (2008)
Visceral Obesity Predicts Surgical Outcomes after Laparoscopic Colectomy for Sigmoid Colon Cancer
Shingo Tsujinaka et al.
DISEASES OF THE COLON & RECTUM (2008)
Obesity and Type 2 Diabetes are Associated with an Increased Risk of Developing Cancer and a Worse Prognosis; Epidemiological and Mechanistic Evidence
D. LeRoith et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2008)
Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus
Rahul Pannala et al.
GASTROENTEROLOGY (2008)
Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus A Systematic Review and Meta-analysis
Bethany B. Barone et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2008)
Endogenous sex hormones and prostate cancer: A collaborative analysis of 18 prospective studies
Andrew W. Roddam et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
Andrew G. Renehan et al.
LANCET (2008)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
General and Abdominal Adiposity and Risk of Death in Europe
T. Pischon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Potential of Peroxisome Proliferator-Activated Receptor Gamma Antagonist Compounds as Therapeutic Agents for a Wide Range of Cancer Types
Jack D. Burton et al.
PPAR RESEARCH (2008)
The Role of PPARs in Cancer
Keisuke Tachibana et al.
PPAR RESEARCH (2008)
The role of insulin receptors and IGF-I receptors in cancer and other diseases
Francesco Frasca et al.
ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY (2008)
Insulin and insulin-like growth factor signalling in neoplasia
Michael Pollak
NATURE REVIEWS CANCER (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
IGF-II and IGFBP-2 differentially regulate PTEN in human breast cancer cells
C. M. Perks et al.
ONCOGENE (2007)
Diabetes mellitus and risk of breast cancer: A meta-analysis
Susanna C. Larsson et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes mellitus and risk of endometrial cancer: a meta-analysis
E. Friberg et al.
DIABETOLOGIA (2007)
Hyperglycemia regulates thioredoxin-ROS activity through induction of thioredoxin-interacting protein (TXNIP) in metastatic breast cancer-derived cells MDA-MB-231
Francesco Turturro et al.
BMC CANCER (2007)
The underuse of screening services among elderly women with diabetes
A. Marshall McBean et al.
DIABETES CARE (2007)
Less aggressive treatment and worse overall survival in cancer patients with diabetes: A large population based analysis
Lonneke V. van de Poll-Franse et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Diabetes and risk of endometrial cancer: A population-based prospective cohort study
Emilie Friberg et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
DPPIV inhibitors extend GLP-2 mediated tumour promoting effects on intestinal cancer cells
K. Masur et al.
REGULATORY PEPTIDES (2006)
Diabetes mellitus and risk of bladder cancer: a meta-analysis
S. C. Larsson et al.
DIABETOLOGIA (2006)
Physical activity and risk of colon and rectal cancers:: The European Prospective Investigation into Cancer and Nutrition
Christine Friedenreich et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Metformin is an AMP kinase-dependent growth inhibitor for breast cancer cells
Mahvash Zakikhani et al.
CANCER RESEARCH (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Obesity and cancer risk: the role of the insulin-IGF axis
Andrew G. Renehan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2006)
Body size and risk of colon and rectal cancer in the European prospective investigation into cancer and nutrition (EPIC)
Tobias Pischon et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Inflammation and insulin resistance
Steven E. Shoelson et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data
Alan D. Lopez et al.
LANCET (2006)
Association between diabetes mellitus and adverse characteristics of breast cancer at presentation
Ido Wolf et al.
EUROPEAN JOURNAL OF CANCER (2006)
Anthropometry, physical activity, and the risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition
Amy Berrington de Gonzalez et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
The association between diabetes and hepatocellular carcinoma: A systematic review of epidemiologic evidence
HB El-Serag et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulforrylureas or insulin
SL Bowker et al.
DIABETES CARE (2006)
Diabetes mellitus and risk of colorectal cancer: A meta-analysis
SC Larsson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2005)
Leptin, insulin-like growth factor-1, and insulin-like growth factor-2 are Mitogens in ApcMin/+ but not Apc+/+ colonic epithelial cell lines
JI Fenton et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Dipeptidyl peptidase IV inhibitors: How do they work as new antidiabetic agents?
CHS McIntosh et al.
REGULATORY PEPTIDES (2005)
Undertreatment of obese women receiving breast cancer chemotherapy
JJ Griggs et al.
ARCHIVES OF INTERNAL MEDICINE (2005)
Type-II diabetes and pancreatic cancer:: a meta-analysis of 36 studies
R Huxley et al.
BRITISH JOURNAL OF CANCER (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Comorbidity as a predictor of stage of illness for patients with breast cancer
ST Fleming et al.
MEDICAL CARE (2005)
Fasting serum glucose level and cancer risk in Korean men and women
SH Jee et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Therapy Insight: influence of type 2 diabetes on the development, treatment and outcomes of cancer
LC Richardson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men
DE Laaksonen et al.
DIABETES CARE (2004)
Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate/cytarabine regimen
MA Weiser et al.
CANCER (2004)
Obesity and colon cancer:: Does leptin provide a link?
P Stattin et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Body size and breast cancer risk:: Findings from the european prospective investigation into cancer and nutrition (EPIC)
PH Lahmann et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
Insulin-like growth factor-I and cancer risk
YH Ibrahim et al.
GROWTH HORMONE & IGF RESEARCH (2004)
Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults
SS Coughlin et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Diabetes mellitus and risk of prostate cancer: a meta-analysis
S Bonovas et al.
DIABETOLOGIA (2004)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
Type 2 diabetes and subsequent incidence of breast cancer in the Nurses' Health Study
KB Michels et al.
DIABETES CARE (2003)
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults
EE Calle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Impact of diabetes mellitus on outcomes in patients with colon cancer
JA Meyerkardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Screening mammogram utilization in women with diabetes
TJ Beckman et al.
DIABETES CARE (2001)
Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk:: a prospective study
P Stattin et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
分享论文
